Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Kersten D. Landa"'
Autor:
Kersten D. Landa, Esther Oomen-de Hoop, Marthe S. Paats, G.D. Marijn Veerman, Ron H.J. Mathijssen, Robert Peric, Anne-Marie C. Dingemans, Teun van Gelder, Cor van der Leest, Suzanna D. Broerse, Stijn L.W. Koolen, Hugo B. Rutten, Christi M.J. Steendam, Huub Belderbos, Koen G. A. M. Hussaarts, Roelof W F van Leeuwen, Joachim G.J.V. Aerts
Publikováno v:
Clinical Pharmacokinetics
Clinical Pharmacokinetics, 60(1), 69-77. Adis
Clinical Pharmacokinetics, 60(1), 69-77. Adis
Introduction: Erlotinib’s gastrointestinal solubility and absorption are decreased by proton pump inhibitors (PPIs). Since erlotinib is a lipophilic drug, we hypothesized that concomitant intake with the fatty beverage milk may be a feasible way to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e790cd1b0f87889be0200663d1844124
https://doi.org/10.1007/s40262-020-00910-1
https://doi.org/10.1007/s40262-020-00910-1
Autor:
Veerman, G. D. Marijn, Hussaarts, Koen G. A. M., Peric, Robert, Oomen-de Hoop, Esther, Landa, Kersten D., van der Leest, Cor H., Broerse, Suzanna D., Rutten, Hugo B., Belderbos, Huub N. A., Steendam, Christi M. J., Paats, Marthe S., Koolen, Stijn L. W., Dingemans, Anne-Marie C., van Gelder, Teun, van Leeuwen, Roelof W. F., Aerts, Joachim G. J. V., Mathijssen, Ron H. J.
Publikováno v:
Clinical Pharmacokinetics; Jan2021, Vol. 60 Issue 1, p69-77, 9p